Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials.
about
Impact of tofacitinib on patient outcomes in rheumatoid arthritis - review of clinical studiesHistamine and Histamine H4 Receptor Promotes Osteoclastogenesis in Rheumatoid Arthritis.Update on the 2012 Brazilian Society of Rheumatology Guidelines for the treatment of rheumatoid arthritis: position on the use of tofacitinib.2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty.Could tofacitinib, the first oral small-molecule inhibitor proven for use in active rheumatoid arthritis (RA) patients with insufficient response to methotrexate, be the breakthrough drug for RA?Novel mechanisms to inhibit HIV reservoir seeding using Jak inhibitors.An overview of meta-analysis for clinicians.Comparative efficacy and safety of tofacitinib, with or without methotrexate, in patients with active rheumatoid arthritis: a Bayesian network meta-analysis of randomized controlled trials.Chronic Pain in Inflammatory Arthritis: Mechanisms, Metrology, and Emerging Targets-A Focus on the JAK-STAT Pathway.2017 American College of Rheumatology/American Association of Hip and Knee Surgeons Guideline for the Perioperative Management of Antirheumatic Medication in Patients With Rheumatic Diseases Undergoing Elective Total Hip or Total Knee Arthroplasty
P2860
Q26772850-4DB6CB4D-C556-4D48-8404-91B1966B3EE2Q33683442-B2AB7210-D183-4706-99C7-D4735C881107Q38604390-D9062B7B-624F-4C73-BA9C-64474C650CEEQ39377679-5C1557A4-8EBC-4651-AA79-6ED3B9FE7EABQ42878305-EBDC01F8-7EF5-44FF-892D-D1EAE8427A3AQ47561974-7A9C3A8F-A69A-407A-BFEA-479BA5F83A70Q49582356-3FD5C08C-E649-4BFE-AF91-1A69E26F21F9Q50910994-69676C34-DD69-4753-8453-202862B03E81Q55027042-7D260155-DA3F-4FF1-AD93-81E752024227Q57245353-A87DA383-E7E8-4E9C-AD43-9EDCC0006965
P2860
Efficacy and safety of tofacitinib for active rheumatoid arthritis with an inadequate response to methotrexate or disease-modifying antirheumatic drugs: a meta-analysis of randomized controlled trials.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Efficacy and safety of tofacit ...... randomized controlled trials.
@en
type
label
Efficacy and safety of tofacit ...... randomized controlled trials.
@en
prefLabel
Efficacy and safety of tofacit ...... randomized controlled trials.
@en
P2860
P1476
Efficacy and safety of tofacit ...... randomized controlled trials.
@en
P2093
Gwan Gyu Song
Young Ho Lee
P2860
P304
P356
10.3904/KJIM.2014.29.5.656
P577
2014-08-28T00:00:00Z